Zobrazeno 1 - 10
of 943
pro vyhledávání: '"Vuagnat A"'
Autor:
Alexandre de Moura, Perrine Vuagnat, Benjamin Renouf, Jean-Yves Pierga, Delphine Loirat, Pauline Vaflard, Charline Lafayolle de la Bruyère, Natacha Chaumard-Billotey, Nawale Hajjaji, Sylvain Ladoire, Sandrine Dabakuyo, Anne Patsouris, Jean Sébastien Frenel, Vincent Nicolai, Marie Alexandre, Nadine Dohollou, Julien Grenier, Heloïse Bourien, François-Clément Bidard
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Following the results of the IMpassion130 trial, an early access program (EAP) was opened in France, allowing patients with PD-L1-positive advanced triple negative breast cancer (aTNBC) to receive a combination of paclitaxel and atezolizumab
Externí odkaz:
https://doaj.org/article/32a11dfa386a4c37a6ba7f6ce998b444
Autor:
Naouri, Diane, Pham, Tai, Dres, Martin, Vuagnat, Albert, Beduneau, Gaëtan, Mercat, Alain, Combes, Alain, Kimmoun, Antoine, Schmidt, Matthieu, Demoule, Alexandre, Jamme, Matthieu
Publikováno v:
In Journal of Infection August 2023 87(2):120-127
Autor:
Diane Naouri, Albert Vuagnat, Gaëtan Beduneau, Martin Dres, Tai Pham, Alain Mercat, Alain Combes, Alexandre Demoule, Antoine Kimmoun, Matthieu Schmidt, Matthieu Jamme
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Introduction Studies regarding coronavirus disease 2019 (COVID-19) were mainly performed in the initial wave, but some small-scale data points to prognostic differences for patients in successive waves. We therefore aimed to study the impact
Externí odkaz:
https://doaj.org/article/0d5646848e3845878345f406f6bf28bc
Autor:
Francoise Difoum, Antoine Schernberg, Hélène Vanquaethem, Hugo Picchi, Audrey Le Roy, Perrine Vuagnat, Carole Helissey
Publikováno v:
Cancer Reports, Vol 6, Iss 7, Pp n/a-n/a (2023)
Abstract Background Immunotherapy alone or in combination has clearly improved the survival of patients with lung cancer. However, it may also be responsible for adverse events impacting these patients' quality of life. The ToxImmune study aims to id
Externí odkaz:
https://doaj.org/article/22f697b8a3cf49a78c02ebcd202ae0be
Autor:
Diane Naouri, Albert Vuagnat, Gaëtan Beduneau, Martin Dres, Tai Pham, Alain Mercat, Alain Combes, Alexandre Demoule, Antoine Kimmoun, Matthieu Schmidt, Matthieu Jamme
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/947a6c0c54764c939415c11946451fd7
Autor:
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amelie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel-Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurelien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean-Charles Soria, Christophe Massard, Aurelien Marabelle
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-14 (2022)
Abstract Background We aimed to determine the safety and efficacy of nintedanib, an oral anti-angiogenic tyrosine kinase inhibitor, in combination with pembrolizumab, an anti-PD1 immunotherapy, in patients with advanced solid tumors (PEMBIB trial; NC
Externí odkaz:
https://doaj.org/article/cc022ab82e6e4fd69d684a17c4dfa3ff
Autor:
de Moura, Alexandre1,2 (AUTHOR) alexandre.demoura@curie.fr, Vuagnat, Perrine1,2 (AUTHOR), Renouf, Benjamin1 (AUTHOR), Pierga, Jean-Yves1,3 (AUTHOR), Loirat, Delphine1 (AUTHOR), Vaflard, Pauline1 (AUTHOR), Lafayolle de la Bruyère, Charline4 (AUTHOR), Chaumard-Billotey, Natacha5 (AUTHOR), Hajjaji, Nawale6,7 (AUTHOR), Ladoire, Sylvain8 (AUTHOR), Dabakuyo, Sandrine8 (AUTHOR), Patsouris, Anne9 (AUTHOR), Frenel, Jean Sébastien9 (AUTHOR), Nicolai, Vincent10 (AUTHOR), Alexandre, Marie11 (AUTHOR), Dohollou, Nadine12 (AUTHOR), Grenier, Julien13 (AUTHOR), Bourien, Heloïse14 (AUTHOR), Bidard, François-Clément1,2 (AUTHOR)
Publikováno v:
Scientific Reports. 11/20/2023, Vol. 13 Issue 1, p1-7. 7p.
Autor:
C. Helissey, C. Parnot, C. Rivière, C. Duverger, A. Schernberg, S. Becherirat, H. Picchi, A. Le Roy, P. Vuagnat, R. Pristavu, H. Vanquaethem, L. Brureau
Publikováno v:
Frontiers in Digital Health, Vol 5 (2023)
Research aim and purposeThe benefits of Electronic Patient -Reported Outcomes (e-PRO) for telemonitoring are well established, allowing early detection of illnesses and continuous monitoring of patients. The primary objective of the PROTECTY study wa
Externí odkaz:
https://doaj.org/article/11990258219a4d839de2c10ec42073d2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marc-Antoine Sanchez, Albert Vuagnat, Olivier Grimaud, Emmanuelle Leray, Jean-Marc Philippe, François-Xavier Lescure, Mathieu Boutonnet, Hélène Coignard, Agnès Ricard Hibon, Stephane Sanchez, Julien Pottecher
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Background The first wave of the COVID-19 pandemic confronted healthcare systems around the world with unprecedented organizational challenges, particularly regarding the availability of intensive care unit (ICU) beds. One strategy implement
Externí odkaz:
https://doaj.org/article/636771b4dde84c0aab47bdedf5a32de9